Swissmedic to cut around 45 full-time positions within two years
Keystone-SDA
The Swiss agency for therapeutic products Swissmedic plans to shed around 45 full-time jobs over the next two years.
+ Get the most important news from Switzerland in your inbox
The move comes as the regulator faces falling revenues and rising costs, which are expected to result in a loss of CHF23.4 million ($29 million) in 2024.
Swissmedic expects to remain in the red in 2025 and beyond under current conditions, the agency said on Tuesday. It noted that in recent years it has built up reserves and, as announced in 2023, has been drawing on them to fund a digital overhaul aimed at making its systems fit for the future.
Stricter EU regulations, a digital transformation drive and tighter oversight of medicines have all contributed to a rise in staff numbers, the agency said in a statement. The biggest savings will come from cutting investment and personnel costs. Over the next two years, Swissmedic aims to trim material expenses by at least CHF6 million and shed around 45 of its 510 full-time jobs.
Translated from German with DeepL/sp
We select the most relevant news for an international audience and use automatic translation tools to translate them into English. A journalist then reviews the translation for clarity and accuracy before publication.
Providing you with automatically translated news gives us the time to write more in-depth articles. The news stories we select have been written and carefully fact-checked by an external editorial team from news agencies such as Bloomberg or Keystone.
If you have any questions about how we work, write to us at english@swissinfo.ch.
